Drosophila melanogaster mutants with deficient kynurenine (KYN) formation from tryptophan (TRP) have longer life span than wild type flies. Administration of alpha-methyl-TRP and 5-methyl-TRY, the inhibitors of TRP-KYN metabolism, prolonged life span in wild-type flies. Both inhibitors are not available for human use. Berberine, an isoquinoline alkaloid isolated from berberis aristata is known as the herb widely used in traditional Chinese and Indian medicine. Berberin is a strong inhibitor of the enzyme catalyzing TRP conversion into KYN. Considering this particular feature we investigated the effect of berberine on life-and health-span in wild-type Drosophila melanogaster . The results of our study showed that Berberine extended mean, median and maximum life span of female flies. Berberine did not affect the number of pupae of filial generation and decreased their lethality. Berberine increased locomotor activity (vertical climbing). The results of the study suggest that berberine prolongs life- and improves health-span of Drosophila melanogaster . Berberine might be a candidate drug for prevention and treatment of aging and aging-associated medical and psychiatric disorders.
G.Oxenkrug, ”Interferon-gamma-inducible kynurenines/ pteridines inflammation cascade: implications for aging and aging-associated medical and psychiatric disorders”, J Neural Transm, Vol.118, No. 1, 2011, pp. 75 – 85 http://dx.doi.org/10.1007/s00702-010-0475-7 PMid:20811799 PMCid:
G. Oxenkrug, “Interferon-gamma–Inducible Inflammation: Contribution to Aging and Aging-Associated Psychiatric Disorders”. Aging and Disease. Vol. 2, No.6, 2011, pp. 474-486. PMid:22396896 PMCid:3295064
KG. Iliadi, GL. Boulianne, “Age-related behavioral changes in Drosophila”, Ann N Y Acad Sci, Vol. 1197, June, 2010, pp. 9-18. http://dx.doi.org/10.1111/j.1749-6632.2009.05372.x PM-id:20536827
MG. Kamyshev, “Longevity and its relation to the locomotor activity in tryptophan-xanthommatin metabolic pathway mutant of Drosophila]”. Dokl. Acad. Nauk. USSR. Vol. 253, No. 5, 1980; pp. 1476 – 1480.
G. Oxenkrug, “The extended life span of Drosophila melanogaster eye-color (white and vermilion) mutants with impaired formation of kynurenine”, J Neural Transm, Vol. 117, No.1, 2010, pp. 23 – 26. http://dx.doi.org/10.1007/s00702-009-0341-7 PMid:19941150 PMCid:3013506
G. Oxenkrug, V. Navrotskaya, L. Vorobyova, P. Summergrad, “Extension of life span of Drosophila melanogaster by the inhibitors of tryptophan – kynurenine metabolism,” Fly (Austin). Vol. 5, No.4, 2011, pp.307 – 309. http://dx.doi.org/10.4161/fly.5.4.18414 PMCid:3266072
CJ. Yu, MF. Zheng, CX. Kuang, WD. Huang, Q. Yang, ” Orengedokuto and its constituents with therapeutic potential in Alzheimer's disease inhibit indoleamine 2, 3-dioxygenase activity in vitro”, J Alzheimers Dis, Vol.22, No.1, 2010, pp. 257-266.PMid:20847417
A. Avanesian, B. Khodayari, JS. Felgner, M. Jafari, “Lamotrigine extends lifespan but compromises health span in Drosophila melanogaster”, Biogerontology. Vol. 11, No. 1, 2010, pp. 45-52. http://dx.doi.org/10.1007/s10522-009-9227-1 PMid:19430925 PMCid:2797622
MA. Jones, M. Grote-wiel, “Drosophila as a model for age-related impairment in locomotor and other behaviors”. Exp Gerontol, Vol. 46, 2011, pp. 320-325. http://dx.doi.org/10.1016/j.exger.2010.08.012 PMid:20800672 PMCid:3021004
DC. Crowther, KJ. Kinghorn, E. Miranda E, et al,” Intraneuronal Aβ, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease,” Neuroscience, Vol. 132, 2005, pp.123-135. http://dx.doi.org/10.1016/j.neuroscience.2004.12.025 PM-id:15780472
P. Masek, K. Scott, “Limited taste discrimination in Drosophila,” Proc Natl Acad Sci U S A, Vol. 107, No.33, 2010, pp.14833-8. http://dx.doi.org/10.1073/pnas.1009318107 PMid:20679196 PMCid:2930483
12. SK. Kulkarni, A. Dhir, “On the mechanism of antidepressant-like action of berberine chloride,” Eur J Pharmacol, Vol. 589, No. 1-3, 2008, pp.163-72. http://dx.doi.org/10.1016/j.ejphar.2008.05.043 PMid:18585703
P. Bhutada, Y. Mundhada, K. Bansod,”Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes”, Behav Brain Res, Vol.220, No.1, 2011, pp. 30-41. http://dx.doi.org/10.1016/j.bbr.2011.01.022 PMid:21262264
GS. Li, XH. Liu, H. Zhu, et al, “ Berberine-improved visceral white adipose tissue insulin resistance associated with altered sterol regulatory element-binding proteins, liver x receptors, and peroxisome proliferator-activated receptors transcriptional programs in diabetic hamsters”, Biol Pharm Bull. Vol. 34, No.5, 2011, pp. 644-654. http://dx.doi.org/10.1248/bpb.34.644
TP. Pham, J. Kwon, J. Shin, “Berberine exerts anti-adipogenic activity through up-regulation of C/EBP inhibitors, CHOP and DEC2”, Biochem Biophys Res Commun,Vol.413, No.2, 2011, pp.376-382. http://dx.doi.org/10.1016/j.bbrc.2011.08.110 PMid:21893041
KV. Anis, NY. Rajeshkumar, R. Kuttan, “ Inhibition of chemical carcinogenesis by berberine in rats and mice”, J Pharm Pharmacol, Vol.53, No.5, 2001, pp.763-768. http://dx.doi.org/10.1211/0022357011775901 PMid:11370717
Harikumar, G. Kuttan, R. Kuttan, ”Inhibition of progression of erythroleukemia induced by Friend virus in BALB/c mice by natural products-berberine, curcumin and picroliv”, J Exp Ther Oncol, Vol. 7, No.4, 2008, pp.275-84. PMid:19227007
S. Campesan, EW Green, C. Breda C, KV Sathyasaikumar, PJ Muchowski, R. Schwarcz, CP Kyriacou, “The Kynurenine Pathway Modulates Neurodegeneration in a Drosophila Model of Huntington's Disease”, Curr Biol, Vol.21, No. 11, pp. 961-966. http://dx.doi.org/10.1016/j.cub.2011.04.028 PMid:21636279
GF. Oxenkrug, “Genetic and hormonal regulation of the kynurenine pathway of tryptophan metabolism: new target for clinical intervention in vascular dementia, depression and aging”, Ann. N Y Acad. Sci, Vol. 1122, December, 2007, pp. 35-49. http://dx.doi.org/10.1196/annals.1403.003 PM-id:18077563
EW. Green, S. Campesan, C. Breda, KV. Sathyasaikumar, PJ. Muchowski, R. Schwarcz, CP. Kyriacou, F. Giorgini,” Drosophila eye color mutants as therapeutic tools for Huntington disease,” Fly (Austin). Vol. 6, No.2, 2012, [Epub ahead of print] http://dx.doi.org/10.4161/fly.19999 PMid:22634544
K. Groebe, F. Krause, B. Kunstmann, et al. “Differential proteomic profiling of mitochondria from Podospora anserina, rat and human reveals distinct patterns of age-related oxidative changes”. Experimental Gerontology. Vol. 42, No.9, 2007, pp. 887-898, http://dx.doi.org/10.1016/j.exger. 2007.07.001
JT. Hwang, DY. Kwon, SH. Yoon “AMP-activated protein kinase: a poten-tial target for the diseases prevention by natural occurring polyphenols”. Biotechnol, Vol. 26, No. 1-2, 2009, pp.17-22.